Results of kinetic measurements are presented which indicate that the reactions of alkyl halides with vitamin B^,, cobaloximes(I), and other Co(I) chelates proceed by a classical Sn2 mechanism, the Co(I) centers being some of the most powerful nucleophiles known. The evidence for this mechanism providing the dominant reaction pathway is based mainly on the analysis of substrate structural effects on the substitution rates. Although the absolute reactivities of the Co(I) nucleophiles are up to 107 times greater than those, e.g., of iodide ion, the relative reactivities with various substrates are very similar. Surprisingly, the rates of reactions of the alkyl halides studied are no more sensitive to steric effects of the corrin ligand system than to those of the cobaloxime moiety. Steric hindrance by out-of-plane corrin ligands appear in later stages of the Co-C bond formation process, as evidenced by the instability of secondary alkyl cobalamins in contrast to the corresponding cobaloxime derivatives. The factors influencing the nucleophilicity of the Co(I) chelates, in particular, the effects of axial bases, ligand structure, and possible mechanistic alternatives of the alkylation reactions are discussed. The presence of the coordinated 5,6-dimethylbenzimidazole does not cause a substantial change of the Co(I) nucleophilicity of vitamin Bn"(5) G.

No abstract

No abstract

Plasma concentrations of proteins secreted by the liver (prealbumin, haptoglobin, transferrin, ceruloplasmin, alpha 1-antitrypsin, antithrombin III, and T4-binding globulin) and proteins mainly derived from endothelium [fibronectin, angiotensin-converting enzyme (ACE), and factor VIII-related antigen (F VIII R:Ag)] were measured in 27 hyperthyroid and 30 normal women. Significantly increased plasma concentrations (P less than 0.01) of endothelium-associated proteins, including fibronectin, ACE, and F VIII R:Ag, were found in hyperthyroid patients, while levels of proteins of primarily hepatic origin were normal. To determine whether the increase in endothelium-associated proteins in hyperthyroidism was directly related to elevated thyroid hormone levels, seven normal women were given T3 (25 micrograms, three times daily) for 2 weeks. These women had a consistent rise (P less than 0.05) in plasma concentrations of fibronectin, ACE, F VIII R:Ag, and tissue plasminogen activator. The rise in endothelium-associated proteins persisted for 10 days after cessation of T3. Plasma concentrations of hepatically synthesized proteins did not change. We conclude that thyroid hormone action either promotes endothelial protein synthesis or impairs its clearance.

No abstract